ModernVivo Introduces Marketplace to Expedite Preclinical CRO Selection for Researchers
In the rapidly evolving field of preclinical research, efficient execution of in vivo studies is crucial. Recognizing this need, ModernVivo has just launched its innovative Marketplace service, designed to significantly enhance the process by which preclinical research teams find and connect with the appropriate Contract Research Organizations (CROs). As pressures mount to not only finalize study designs but also to execute them swiftly, delays in CRO selection can severely impact research timelines and drug development processes.
The need for an effective solution is clear. For researchers, the traditional route of identifying suitable CROs is not only time-consuming but also fraught with challenges. Often, researchers must sift through numerous candidates, assessing their specialized skills and qualifications, a process that can take months. This delay can hinder critical research timelines, jeopardizing the progression of potential new treatments and therapies into clinical trials.
To alleviate these challenges, the ModernVivo Marketplace offers a smart and streamlined connecting platform that can match biotech and pharmaceutical teams with pre-vetted CROs in a matter of days. Unlike conventional methods that base matches solely on broad therapeutic areas, this Marketplace takes a sophisticated approach. It accounts for specific study models, endpoints, and protocol requirements that define each project. As a result, researchers can quickly pinpoint the CRO that best aligns with their precise needs, drawing from a diverse network of vendors spread across North America, Europe, and the Asia-Pacific region.
For preclinical teams, this shift to faster, more reliable development represents a significant advancement in how they approach study design and execution. By utilizing a platform that is already attuned to the specific requirements of their projects, teams can minimize guesswork, allowing them to advance their research efforts with newfound confidence.
On the flip side, CROs also benefit immensely from this service. The Marketplace connects them with potential clients who have already established requirements that match the CRO's technical capabilities. This means that CROs not only get pre-qualified leads but also enhance their visibility among researchers who are specifically looking for their expertise. For many CROs, the ModernVivo Marketplace represents an opportunity to engage with high-value prospects in a more efficient manner, ultimately improving their operational pipeline.
As Ian Levine, Co-Founder and CEO of ModernVivo, emphasizes, "We are the only platform that not only aids teams in designing their studies but also facilitates connections to organizations that can execute the experiments. Our goal is to make the development process as seamless as possible, and the Marketplace is a crucial step towards achieving that. For teams already using ModernVivo Scholar, this Marketplace is free, as well as for new users, enhancing accessibility and user engagement."
ModernVivo itself is a cutting-edge literature intelligence platform tailored for the realm of preclinical drug discovery and development. The platform empowers researchers by analyzing millions of peer-reviewed publications, assisting in identifying relevant in vivo models, extracting detailed experimental conditions, and comparing findings with clinical trial data and regulatory guidelines. By integrating this Marketplace functionality, ModernVivo is extending its mission beyond study design to encompass the entire study execution process, ensuring that researchers can transition from inquiry to execution with greater speed and assurance.
In conclusion, the launch of the ModernVivo Marketplace marks a pivotal moment in the landscape of preclinical research. By simplifying the connection between researchers and CROs, the platform is set to not only streamline operations but also expedite timelines for developing novel therapies. As the industry moves forward, tools like the ModernVivo Marketplace represent the future of more efficient clinical research processes, paving the way for potentially groundbreaking treatments to reach patients sooner than ever before.
The need for an effective solution is clear. For researchers, the traditional route of identifying suitable CROs is not only time-consuming but also fraught with challenges. Often, researchers must sift through numerous candidates, assessing their specialized skills and qualifications, a process that can take months. This delay can hinder critical research timelines, jeopardizing the progression of potential new treatments and therapies into clinical trials.
To alleviate these challenges, the ModernVivo Marketplace offers a smart and streamlined connecting platform that can match biotech and pharmaceutical teams with pre-vetted CROs in a matter of days. Unlike conventional methods that base matches solely on broad therapeutic areas, this Marketplace takes a sophisticated approach. It accounts for specific study models, endpoints, and protocol requirements that define each project. As a result, researchers can quickly pinpoint the CRO that best aligns with their precise needs, drawing from a diverse network of vendors spread across North America, Europe, and the Asia-Pacific region.
For preclinical teams, this shift to faster, more reliable development represents a significant advancement in how they approach study design and execution. By utilizing a platform that is already attuned to the specific requirements of their projects, teams can minimize guesswork, allowing them to advance their research efforts with newfound confidence.
On the flip side, CROs also benefit immensely from this service. The Marketplace connects them with potential clients who have already established requirements that match the CRO's technical capabilities. This means that CROs not only get pre-qualified leads but also enhance their visibility among researchers who are specifically looking for their expertise. For many CROs, the ModernVivo Marketplace represents an opportunity to engage with high-value prospects in a more efficient manner, ultimately improving their operational pipeline.
As Ian Levine, Co-Founder and CEO of ModernVivo, emphasizes, "We are the only platform that not only aids teams in designing their studies but also facilitates connections to organizations that can execute the experiments. Our goal is to make the development process as seamless as possible, and the Marketplace is a crucial step towards achieving that. For teams already using ModernVivo Scholar, this Marketplace is free, as well as for new users, enhancing accessibility and user engagement."
ModernVivo itself is a cutting-edge literature intelligence platform tailored for the realm of preclinical drug discovery and development. The platform empowers researchers by analyzing millions of peer-reviewed publications, assisting in identifying relevant in vivo models, extracting detailed experimental conditions, and comparing findings with clinical trial data and regulatory guidelines. By integrating this Marketplace functionality, ModernVivo is extending its mission beyond study design to encompass the entire study execution process, ensuring that researchers can transition from inquiry to execution with greater speed and assurance.
In conclusion, the launch of the ModernVivo Marketplace marks a pivotal moment in the landscape of preclinical research. By simplifying the connection between researchers and CROs, the platform is set to not only streamline operations but also expedite timelines for developing novel therapies. As the industry moves forward, tools like the ModernVivo Marketplace represent the future of more efficient clinical research processes, paving the way for potentially groundbreaking treatments to reach patients sooner than ever before.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.